Skip to main content

Abstract

Background—

Food deserts (FD), neighborhoods defined as low-income areas with low access to healthy food, are a public health concern. We evaluated the impact of living in FD on cardiovascular risk factors and subclinical cardiovascular disease (CVD) with the hypothesis that people living in FD will have an unfavorable CVD risk profile. We further assessed whether the impact of FD on these measures is driven by area income, individual household income, or area access to healthy food.

Methods and Results—

We studied 1421 subjects residing in the Atlanta metropolitan area who participated in the META-Health study (Morehouse and Emory Team up to Eliminate Health Disparities; n=712) and the Predictive Health study (n=709). Participants’ zip codes were entered into the United States Food Access Research Atlas for FD status. Demographic data, metabolic profiles, hs-CRP (high-sensitivity C-reactive protein) levels, oxidative stress markers (glutathione and cystine), and arterial stiffness were evaluated. Mean age was 49.4 years, 38.5% male and 36.6% black. Compared with those not living in FD, subjects living in FD (n=187, 13.2%) had a higher prevalence of hypertension and smoking, higher body mass index, fasting glucose, and 10-year risk for CVD. They also had higher hs-CRP (P=0.014), higher central augmentation index (P=0.015), and lower glutathione level (P=0.003), indicative of increased oxidative stress. Area income and individual income, rather than food access, were associated with CVD risk measures. In a multivariate analysis that included food access, area income and individual income, both low-income area and low individual household income, were independent predictors of a higher 10-year risk for CVD. Only low individual income was an independent predictor of higher hs-CRP and augmentation index.

Conclusions—

Although living in FD is associated with a higher burden of cardiovascular risk factors and preclinical indices of CVD, these associations are mainly driven by area income and individual income rather than access to healthy food.

Introduction

WHAT IS KNOWN

Neighborhood characteristics and socioeconomic status have been linked to unfavorable cardiovascular risk profile and health outcomes.
Previous literature suggested that adverse effects of the environment may be because of low access to healthy food.

WHAT THE STUDY ADDS

The study demonstrates an association between living in food deserts and inflammation, oxidative stress, and arterial stiffness.
We demonstrate that the higher prevalence of cardiovascular risk factor burden, oxidative stress, inflammation, and subclinical vascular disease is driven by individual income rather than food access.
Neighborhood environmental characteristics and socioeconomic status (SES) have been linked to health outcomes, especially cardiovascular disease (CVD).1,2 These unfavorable environmental attributes also seem to impact lifestyle behaviors including physical activity and smoking.24 It has long been suspected that the adverse effects of these environments are driven by low access to healthy food for neighborhood residents.5,6 The Coronary Artery Risk Development in Young Adults study reported that an increased prevalence of convenience stores was associated with lower dietary quality, specifically in low-income subjects.7 However, whether other aspects of the socioeconomic neighborhood environment also contribute to geographical differences in CVD health status, and the role played by individual SES, remain a subject of controversy.1,2
See Editorial by Ferdinand and Mahata
A food desert (FD) is defined by the US department of agriculture (USDA) as a location with both low access to healthy food and low income.8 An estimated 23.5 million people live in FD across the United States,8,9 and the White House Task Force on Childhood Obesity recognized FD as a major contributor to a poor dietary pattern and obesity.10 Governmental programs and policies are currently focused on clearing FD areas by funding healthy food options and access.11 However, the direct linkage between FD and health outcomes remains understudied.
The relationship between SES and cardiovascular risk can be studied in the general population by investigating risk factor prevalence and presence of subclinical vascular disease.12 Vascular dysfunction often precedes CVD,13 and previous studies have reported a higher pulse wave velocity (a measure of arterial stiffness) and intima–media thickness in black subjects with lower SES, even in adolescence.14 Chronic inflammation, estimated by circulating hs-CRP (high-sensitivity C-reactive protein) levels, is an established risk factor for diabetes mellitus, hypertension, and CVD and is inversely related to SES.1517 Oxidative stress (OS) is an important initiating factor in the pathogenesis of subclinical and clinical CVD, but its relationship to neighborhood and environmental factors remains unknown.18,19
Few studies have examined the relationship between specific characteristics of disadvantaged neighborhoods, such as living in a FD and a comprehensive set of CVD risk factors and subclinical measures of vascular disease.20 CVD and its risk factors are more prevalent in southeastern United States,21,22 and there is a shift in concentration of cardiovascular mortality from the northeast to deep south.23 Although the reasons are likely to be multifactorial, differences in racial distribution and social determinants seem to play a role. Whether neighborhood access to healthy foods is driving these disparities above and beyond income levels at the personal or neighborhood level remains poorly studied. Herein, we examined the association between living in areas of either low income or low access to healthy food, or both (FD) and the burden of cardiovascular risk factors, inflammation, OS, and subclinical vascular disease. Our hypothesis was that living in a FD would be associated with an unfavorable cardiovascular risk profile and subclinical vascular disease, independent of overall area SES and individual SES.

Methods

Study Sample

We performed a cross-sectional analysis of data from subjects aged 20 to 79 years and residing in the Atlanta metropolitan area who were recruited into the META-Health study (Morehouse and Emory Team up to Eliminate Health Disparities; n=712) or the Predictive Health (PH) study (n=709).24,25 The META-Health (MH) study recruited 753 community participants of whom 721 were eligible and enrolled. Only 712 subjects had valid addresses for determining area characteristics. The Predictive Health study (http://predictivehealth.emory.edu) recruited a cohort of university employees from Emory University and the Georgia Institute of Technology.24,25 Seven hundred eleven subjects were enrolled in the study, and only 709 had valid addresses for neighborhood analysis. There was no significant difference between those who were included and those who were excluded from our analysis. Those with poorly controlled medical conditions, acute illness, recent hospitalization, or pregnant women were excluded. Detailed information on demographics and anthropometrics was collected. Hypertension, hypercholesterolemia, and diabetes mellitus were defined according to the Joint National Committee, Adult Treatment Panel III, and American Diabetes Association criteria, respectively.2628 The Atherosclerotic Cardiovascular Disease in Adults (ASCVD) scores were calculated to estimate the 10-year risk for coronary death or myocardial infarction.29 Subjects signed an informed consent that was approved by the Emory and Georgia Tech institutional review board. Please see the Data Supplement for details.
Each participants’ zip code was entered into the USDA Food Desert Research Atlas that determined their FD status.8 A FD refers to a geographic location with both low income and low access to healthy foods. Low-income areas are defined according to criteria developed by the Department of Treasury’s New Markets Tax Credit program as any area where poverty rate is ≥20% or where the median family income is ≤80% of the state-wide median family income. Areas with low access to healthy foods are defined as areas where a significant share of people live ≥1 mile away in urban areas or ≥10 miles in rural areas from supermarket, supercenter, or large grocery store.8

Laboratory Tests

Participants were instructed to fast for 12 hours before the study visit. Venous blood was collected, and levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and glucose were measured by spectrophotometry. Serum hs-CRP level was measured by immunonephelometry (Siemens/Dade Behring). Markers of OS included plasma levels of the amionthiols, glutathione, and cystine, which were measured using high-performance liquid chromatography as described previously.19,30,31 Low levels of glutathione and high levels of cystine indicate higher OS. Of 1421 subjects enrolled in MH and PH studies, the following data were missing: hs-CRP (69 MH and 7 PH subjects), GSH (41 MH and 98 PH), and cystine (41 MH and 97 PH subjects) because of technical difficulties in sample drawing or processing. Pulse wave velocity (PWV; 295 MH and 24 PH subjects) and augmentation index (AI, 52 MH and 17 PH subjects) data were missing. Only available data were analyzed.

Vascular Function Testing

PWV and AI were estimated in the supine position after an overnight fast using the SphygmoCor device (AtCor Medical, Australia), which records sequential high-quality pressure waveforms at peripheral pulse sites using a high-fidelity tonometer, as described previously.3133 AI is a ratio calculated from blood pressure waveform as the percentage of central pulse pressure to the secondary systolic pressure rise caused by the overlap of the reflected pressure waves.34 Details are available in the Data Supplement.

Statistical Methods

Continuous variables are presented as means±SD when normally distributed, skewed variables (cardiovascular risk scores and hs-CRP) as median (lower and upper quartiles), and categorical variables as proportions. Univariate group differences were compared using the χ2 test for categorical variables and independent t tests for continuous variables. Nonparametric testing (Mann–Whitney) was used for comparing skewed variables, and these values were log transformed before analysis. Multiple linear regression was performed to determine the association of FD, area or personal income, and food access with OS measures and vascular function after adjusting for traditional CVD risk factors, including age, sex, race, smoking, hypertension, hyperlipidemia, diabetes mellitus, and body mass index. Interaction between food access, area, and personal income was performed. We intentionally adjusted for CVD risk factors because of baseline differences of risk factor burden between subjects living in different areas of FD. Individual income and education level were highly correlated in our sample. Therefore, we only adjusted for individual income to reduce multicollinearity. P values <0.05 were considered significant. Analyses were performed using SPSS, Inc (version 23).

Results

Subjects’ Characteristics

Baseline demographic and clinical characteristics of the 1421 subjects are presented in Table 1. The sample was 38.5% male, 36.6% black, mean age 49.4±10.2 years. Education-level assessment revealed that 11% had a high school diploma or less, whereas 63.7% were college graduates. Annual household income in 11.2% was <$25 000, and 47.9% had income >$75 000 (Table 1).
Table 1. Subjects’ Characteristics by Food Desert Status
 TotalFood DesertNon–food DesertP Value
Sample, n14211871234
Age, y49.4±10.249.1±8.849.4±10.50.68
Male sex, %38.538.537.50.80
Black, %36.651.934<0.001
Education (% distribution)   <0.001
 High school graduate or less1122.89.8 
 Some college20.133.319.3 
 College graduate63.743.970.9 
Income (% distribution)   <0.001
 ≤ $25 00011.222.310.8 
 $25 000–$50 00016.227.416.2 
 $50 000–$75 00015.517.717.2 
 >$75 00047.932.655.8 
Hypertension34.547.632.4<0.001
Diabetes mellitus8.911.38.60.22
Hyperlipidemia51.454.351.50.47
Heart disease3.45.53.20.13
Smoking13.321.912.4<0.001
Medication use, %
 Hypertension treatment21.435.822.2<0.001
 Lipid treatment51.414.616.60.52
Metabolic syndrome27.230.6280.46
BMI, mean, kg/m228.9±730.6±828.6±7<0.001
Systolic blood pressure, mm Hg121.4±17125.9±21120.6±16<0.001
Fasting blood glucose, mg/dL91.7±2294.8±3391.2±200.042
Total cholesterol, mg/dL196±38199.5±42196.3±380.29
LDL114.5±33118.3±37.1113.9±330.1
HDL60.8±1859.1±16.561.3±180.12
Triglyceride109.2±63113.1±62.5108.1±640.32
Cardiovascular risk estimation
 ASCVD (IQR)3.0 (1.2–6.6)4.1 (1.7–7.3)2.8 (1.1–6.4)0.007
Inflammatory markers
 Hs-CRP mg/L (IQR)1.6 (0.5–3.8)2.2 (0.9–4.5)1.5 (0.5–3.7)0.014
 Hs-CRP >2 mg/L, %42.752.941.60.005
Oxidative stress markers, µmol/L
 Glutathione1.65±0.631.51±0.581.67±0.640.003
 Cystine84.0±18.585.2±16.683.9±18.80.41
Vascular function
 Pulse wave velocity, m/s7.33±1.527.50±1.797.30±1.480.18
 Augmentation index at 75 bpm21.29±10.723.09±11.321.00±10.60.015
Values shown are mean±SDs or number (%) for normally distributed variables or median (IQR) for non-normally distributed variables. Bold values indicate statistically significant difference (P<0.05). ASCVD indicates atherosclerotic cardiovascular disease in adults; BMI, body mass index; HDL, high-density lipoprotein; Hs-CRP, high-sensitivity C-reactive protein; IQR, interquartile range; and LDL, low-density lipoprotein.

FD Areas and Cardiovascular Risk

The distribution of FD in the Atlanta metro area according to the USDA Food Access Research Atlas is shown in Figure (A). Individuals living in FD areas (n=187, 13.2%) were predominantly black (52% versus 34%) with less college education and lower income compared with those who were not living in FD (Table 1). They also had an unfavorable cardiovascular risk profile with a higher prevalence of hypertension and smoking rates, higher body mass index and fasting blood glucose levels, and a higher ASCVD score (P=0.007). Moreover, they also had higher levels of hs-CRP, lower levels of glutathione, and higher AI compared with those living in non-FD areas (Table 1). These differences remained significant for glutathione and AI after adjustment for traditional risk factors (Tables 1 and 2).
Figure. Distribution of (A) food deserts, (B) areas with low access to healthy food, and (C) low-income areas in the Atlanta metropolitan region according to the US Department of Agriculture Food Access Research Atlas.
Table 2. Estimated Adjusted Differences in Markers of Inflammation, Oxidative Stress, and Vascular Function According to the Status of Food Deserts, Food Access, Area Income, and Individual Income
 Estimated Difference (96% Confidence Interval)
Food Desert vs Non–food DesertLow Food Access vs Good Food AccessLow-Income Area vs High-Income AreaLow Individual Income vs High Individual Income
Inflammatory markers
 Hs-CRP, %5 (−11.8 to 25.2)−6.6 (−16.9 to 5.1)13.8 (1 to 29.3)*20.7 (5.1 to 38.7)*
Oxidative stress markers, µmol/L
 Glutathione−0.12 (−0.22 to −0.02)*0.003 (−0.07 to 0.07)−0.10 (−0.18 to −0.03)*−0.10 (−0.18 to −0.02)*
 Cystine0.377 (−2.49 to 3.25)−0.57 (−2.53 to 1.40)−0.49 (−2.60 to 1.63)−0.74 (−1.54 to 3.03)
Vascular function
 Pulse wave velocity, m/s−0.02 (−0.29 to 0.25)0.09 (−0.08 to 0.25)0.06 (−0.12 to 0.25)0.19 (−0.02 to 0.40)
 Augmentation index at 75 bpm1.47 (0.12 to 2.83)*−0.47 (−1.39 to 0.46)0.43 (−0.59 to 1.45)1.89 (0.80 to 2.99)*
Cardiovascular risk estimation
 ASCVD, %14 (6.4 to 22.1)*0.5 (−4.2 to 5.3)10.2 (4.5 to 16.2)*15.1 (8.7 to 22.1)*
Percent difference was reported for Hs-CRP. Multivariate analysis after adjustment for age, sex, race, hypertension, hyperlipidemia, diabetes mellitus, smoking, body mass index, and heart disease. ASCVD indicates atherosclerotic cardiovascular disease in adults; and Hs-CRP, high-sensitivity C-reactive protein.
*
P<0.05.

Food Access, Area Income, Individual Income, and Cardiovascular Risk

The population was further classified on the basis of residing in neighborhoods and its access to healthy food and area income in addition to individual household income (Table 3; Figure [B and C]). Subjects living in neighborhoods with low access to healthy food were more often black, with lower education level, higher body mass index, and prevalence of hypertension compared with subjects living in favorable food access areas. Similar findings in addition to higher prevalence of diabetes mellitus, smoking, hyperlipidemia, and higher ASCVD score were observed in subjects living in low-income compared with high-income areas. The sample was further classified based on individual income defined as annual household income <$50 000. Similar differences in cardiovascular risk factors were observed in subjects with low compared with high individual income.
Table 3. Subjects’ Characteristics by Food Access, Area, and Individual Income
 Low Food AccessGood Food AccessP ValueLow-Income AreaHigh-Income AreaP ValueLow Individual IncomeHigh Individual IncomeP Value
Sample, n784637 468953 398923
Age, y49.1±1049.7±10.50.3549.± 1049.6±10.40.3848.6±10.549.8±9.90.05
Male sex, %35.340.50.0537.038.00.7339350.19
Black, %39.532.30.00651.728.6<0.0013927<0.001
Education (% distribution)  0.019  <0.001  <0.001
 High school graduate or less12.610 19.87.4 313 
 Some college23.218.6 30.416.7 3714 
 College graduate64.171.3 49.875.9 3282 
Income (% distribution)  0.66  <0.001  
 ≤$25 0001212.7 22.07.6  
 $25 000–$50 00018.716.5 25.813.7  
 $50 000–$75 00017.716.7 18.616.6  
 >$75 00051.554.1 33.662.1  
Hypertension37.530.50.00641.430.9<0.0014232<0.001
Diabetes mellitus8.69.30.6511.47.70.029147<0.001
Hyperlipidemia53.150.30.3056.649.50.01557500.04
Heart disease3.14.10.315.72.50.005530.12
Smoking13.913.40.8120.610.3<0.001287<0.001
Medication use, %
 Hypertension treatment25.4230.1730.920.7<0.00129220.02
 Lipid treatment15.717.30.4516.116.50.9417160.53
Metabolic syndrome3026.30.1530.127.40.3128290.67
BMI, mean, kg/m229.4±7.328.3±6.70.00229.9±7.728.4±6.7<0.00130.6±8.328.2±6.2<0.001
Systolic blood pressure, mm Hg122.1±17.7120.3±16.20.05123.3±19.4120.3±15.70.002124.3±20.2120.2±15.9<0.001
Fasting blood glucose, mg/dL91.7±24.291.6±19.90.8992.7±25.791.1±20.50.2194.3±27.890.8±19.80.012
Total cholesterol, mg/dL198.3±38194.9±38.20.10195.5±40.1197.3±37.10.39195.1±40.6197.9±37.10.002
LDL116.4±34112.3±330.23114.7±36114.4±320.89115.5±35.6114.7±32.40.23
HDL60.4±1861.7±180.1860.1±1861.4±180.2058.7±16.962.1±18.10.68
Triglyceride109.9±62107.3±650.45107.3±59109.4±660.57108.2±58108.3±64.50.002
Cardiovascular risk estimation
 ASCVD (IQR)2.9 (1.2–6.5)3.1 (1.1–6.5)0.724.5 (1.8–8.0)2.8 (1.2–6.4)<0.0015.1 (1.95–8.1)2.6 (1–5.9)<0.001
Inflammatory markers
 Hs-CRP, mg/L (IQR)1.6 (0.5–4.0)1.6 (0.5–3.6)0.732.1 (0.8–4.9)1.5 (0.5–3.4)<0.0012.2 (0.8–5.6)1.5 (0.5–3.4)<0.001
 Hs-CRP >2 mg/L, %43.342.80.8451.339.1<0.00151.939.9<0.001
Oxidative stress markers, µmol/L
 Glutathione1.64±0.611.66±0.610.611.56±0.601.69±0.65<0.0011.5±0.61.7±0.6<0.01
 Cystine83.9±18.484.3±18.40.4784.3±18.584.0±18.90.6984.8±19.183.7±18.50.37
Vascular function
 Pulse wave velocity, m/s7.35±1.547.29±1.500.497.51±1.87.25±1.4<0.0017.5±1.77.2±1.40.014
 Augmentation index at 75 bpm21.35±10.821.20±10.50.8122.0±11.520.9±10.20.00122.4±1220.9±9.90.018
High income is defined as annual income >$50 000. Low income is defined as annual income <$50 000. Values shown are mean±SDs or number (%) for normally distributed variables or median (IQR) for non-normally distributed variables. Bold values indicate statistically significant difference (P<0.05). ASCVD indicates atherosclerotic cardiovascular disease in adults; BMI, body mass index; CVD, cardiovascular disease; HDL, high-density lipoprotein; Hs-CRP, high-sensitivity C-reactive protein; IQR, interquartile range; and LDL, low-density lipoprotein.
The differences in subclinical vascular disease was also examined in subjects based on their neighborhood characteristics and individual SES. There were no differences in the markers of inflammation, OS, or vascular stiffness in those living in low compared with good access to healthy foods (Tables 2 and 3). However, subjects living in low-income areas had a higher hs-CRP levels, lower glutathione levels, higher PWV, and AI compared with subjects residing in higher income areas (Table 3). The differences in hs-CRP and glutathione levels remained significant after adjustment for cardiovascular risk factors (Table 2). Low individual income was also associated with higher levels of hs-CRP, PWV, and AI and lower glutathione level, and the differences remained significant after adjustment for cardiovascular risk factors (Tables 2 and 3).

Relationship Between Cardiovascular Risk and Both Area Income and Food Access

Subjects were separated into 4 categories based on whether they were living in high-income areas with either good (n=356) or low access to healthy foods (n=597), or in low-income areas with either good (n=281) or low access to healthy food (FD, n=187; Figure I through V in the Data Supplement). Subjects living in low-income areas with low food access (FD) had no significant difference in ASCVD score, hs-CRP, PWV, cystine, or glutathione levels compared with subjects living in areas with low income and good food access areas. Only subjects living in low-income areas, irrespective of whether they had good or poor access to healthy food, had higher hs-CRP level and higher OS (low glutathione) when compared with subjects living in high-income areas, regardless of their food access (Figure I through V in the Data Supplement).

Relationship Between Cardiovascular Risk and Both Individual Income and Food Access

Subjects were separated into 4 categories based on whether they were living in areas with good or poor access to healthy food and whether they had high versus low individual income (Table I and Figure I through V in the Data Supplement). There were no significant differences in cardiovascular risk factors, CVD risk estimation, inflammation, arterial stiffness, and OS between subjects with low individual income living in areas with poor or good access to healthy food. Similarly, no differences in these measures were observed in subjects with high individual income living in varying food access areas. Thus, individuals with high income living in areas with low access to healthy food had lower risk factor burden and ASCVD scores (P=0.001), lower hs-CRP levels (P=0.004), and higher glutathione levels (P=0.005) compared with subjects with lower income living in similar low access area (Figure I through V in the Data Supplement). These data indicate that individual income and not food access was a more important contributor to CVD risk.

Relationship Between Cardiovascular Risk and BothIndividual Income and Area Income

The distribution of risk factors, biomarkers, and vascular function was also studied to distinguish the effects of individual versus the area income levels (Table II and Figure I throgh V in the Data Supplement). Subjects with low individual income living in low-income areas were more likely to be black with lower educational level, higher prevalence of diabetes mellitus and smoking, higher hs-CRP levels (P=0.05), higher cardiovascular risk (ASCVD P<0.001), and lower glutathione level (P=0.041) compared with individuals with higher individual income living in low-income areas. Similarly, subjects with low individual income living in high-income areas were more often black with poor education levels, higher ASCVD score, higher Hs-CRP levels, and lower glutathione levels compared with those with high income living in similar high-income areas (Figure I through V in the Data Supplement).

Relationship Between Cardiovascular Risk and Individual Income, Area Income, and Food Access

Multivariate analyses were performed after adjustment for traditional cardiovascular risk factors to investigate which of these SES and neighborhood factors were associated with CVD risk markers. When individual income, area income, and food access were entered into the same model, independent predictors of higher ASCVD risk score were both low individual and low neighborhood income. Only low individual income was an independent predictor of both hs-CRP and AI after adjusting for CVD risk factors. Finally, area income (P=0.031) was also an independent predictor of OS (Table 4). Thus, the major predictors of increased CVD risk were individual and neighborhood income, whereas food access and living in FD were not independent predictors of CVD risk. There was no significant interaction between area income, individual income, and food access with ASCVD risk score, OS, and inflammation. The data were unchanged when adjusted for study cohort.
Table 4. Multivariate Analysis of Area Characteristics/Individual Income and Measures of Inflammation, Arterial Stiffness, Glutathione, and Cardiovascular Disease Risk
 LogCRP, β (CI)AI, β (CI)PWV, m/s, β (CI)Glutathione, β (CI)Cystine, β (CI)LogASCVD, β (CI)
Model 1
 Low individual income0.16 (0.01 to 0.30)*1.56 (0.51 to 2.75)*0.14 (−0.08 to 0.35)−0.08 (−0.16 to 0.005)0.94 (−1.42 to 3.30)0.29 (0.17 to 0.41)*
 Low-income area0.10 (−0.04 to 0.24)0.30 (−0.78 to 1.38)0.14 (−0.07 to 0.34)−0.09 (−0.17 to −0.008)*−0.42 (−2.74 to 1.90)0.14 (0.02 to 0.25)*
 Low food access−0.04 (−0.16 to 0.09)−0.40 (−1.37 to 0.56)0.09 (0.09 to 0.26)−0.01 (−0.09 to 0.06)−0.83 (−2.94 to 1.28)−0.01 (−0.11 to 0.09)
Model 2
 Interaction term: (individual income × area income)−0.14 (−0.42 to 0.13)0.59 (−1.58 to 2.77)−0.25 (−0.67 to 0.18)0.05 (−0.11 to 0.21)−4.35 (−8.94 to 0.25)0.04 (−0.08 to 0.15)
Model 3
 Interaction term: (individual income × food access)0.011 (−0.26 to 0.28)2.7 (0.56 to 4.74)*0.14 (−0.26 to 0.55)−0.06 (−0.21 to 0.10)3.79 (−0.65 to 8.22)−0.04 (−0.15 to 0.08)
Model 4
 Interaction term: (area income × food access)§0.002 (−0.26 to 0.26)3.02 (0.99 to 5.05)*−0.27 (−0.66 to 0.12)−0.09 (−0.24 to 0.06)2.54 (−1.86 to 6.95)0.10 (0.0 to 0.21)
Multivariate analyses controlling age, sex, race, hypertension, hyperlipidemia, diabetes mellitus, smoking, BMI, and heart disease except for ASCVD. Standardized β coefficient displayed with P value. AI indicates augmentation index; ASCVD, atherosclerotic cardiovascular disease in adults; BMI, body mass index; CRP, C-reactive protein; and PWV, pulse wave velocity.
*
Statistically significant difference (P<0.05).
Model 2 included variables in model 1+the interaction term.
Model 3 included model 1+the interaction term.
§
Model 4 included model 1+the interaction term.

Discussion

In a community-based population from the southeastern United States, we demonstrate the clinical impact of living in FD and its components on cardiovascular risk and subclinical vascular disease. We found that subjects living in FD not only had an unfavorable cardiovascular risk profile but also had increased systemic OS, inflammation, and arterial stiffness. Further investigation of individual components of FD showed that its associations with unfavorable health profile were driven by area income rather than food access. Moreover, individual household income showed the most robust impact on the various measures of CVD risk and subclinical vascular disease.
Subclinical measures of vascular risk include measures of systemic inflammation, OS, and subclinical vascular disease, including arterial stiffness. These measures estimate activation of pathophysiologic processes that lead to initiation and progression of CVD and are independently predictive of adverse long-term outcomes.19 Similarly, measures of subclinical vascular disease integrate the injury from risk factors on the vascular wall and are also predictive of future adverse outcomes.13,35,36 In this study, we not only demonstrate that CVD risk scores are higher in individuals living in low-income neighborhoods or with lower personal income but also show that these factors were significantly associated with inflammation, OS, and arterial stiffness.

Food Deserts

The present study is the first to report the relationship between living in FD (defined as both low income and access to healthy food areas by the USDA), cardiovascular risk factors, and subclinical vascular disease. Previous studies have focused on select neighborhood characteristics and SES in addition to composite scores of neighborhood features.2,37 For example, areas with poor food quality, low access to healthy foods, or more fast-food restaurants are associated with obesity and diabetes mellitus risks.38,39 A recent study showed that although living in FDs was associated with decreased fruit and vegetable intake and higher systolic blood pressure, low individual income rather than FDs was associated with higher odds of chronic kidney disease.40 Novel findings of our study are the relationships between FD and subclinical CVD measured as vascular dysfunction, inflammation, and OS, and the fact that these are driven by income rather than access to healthy foods.13,19

Food Access

There is controversy on the cardiovascular health effects of food access.41,42 In the Atherosclerosis Risk in Communities study, increased prevalence of convenience stores was associated with a higher incidence of obesity but not diabetes mellitus, hypertension, or dyslipidemia.43 However, other studies did not confirm these findings.38,44 We found that living in areas with low access to healthy food was not associated with a higher CVD risk, inflammation, OS, or arterial stiffness compared with subjects living in areas with good access to healthy food. Thus, food access by itself, measured by proximity to supermarkets, might not contribute to increased cardiovascular risk, and the relative cost of higher quality food rather than access may be a major barrier to healthy lifestyle and choices.6,45

Area and Individual Income

The relationship between SES and CVD risk is well established.2,37,4648 There is striking geographical variation in the distribution of cardiovascular risk factors and CVD mortality in the United States.49 Neighborhood SES, deprivation, lack of cohesion, decreased access to recreational resources, lack of public space, and safety are some of the factors that can affect these outcomes.1 The income status of neighborhoods can also influence the diversity of food resources, prices, and, thus, food access.50,51 Our analyses showed that the income status of areas is an independent determinant of cardiovascular risk and subclinical vascular disease.
Our study also showed that it was the individual income, rather than the neighborhood income or food access, that was associated with higher risk of developing CVD, inflammation, and OS. Thus, people with high individual income who lived in low-income areas had lower CVD risk and inflammation compared with subjects with lower individual income who lived in similar area. Moreover, people with high individual income who lived in an area with poor food access had better cardiovascular profile than those with lower individual income who lived in similar area. It seems that the adverse association of FD with health is partly driven by the area income and most importantly by individual income status, rather than access to food. There are several initiatives that promote healthy food access by providing incentives for individuals with low income. Georgia provides incentives for participants in the Supplemental Nutrition Assistance Program to increase the value of Supplemental Nutrition Assistance Program benefits if healthy food is purchased at farmers’ markets. However, few farmers’ markets are located in FDs and few accept Supplemental Nutrition Assistance Program in Georgia.52 Providing support services for eligible low-income families may overcome some of the adverse health outcomes driven by low SES. A recent report by the Center for Disease Control and Prevention showed that enrollment in Supplemental Nutrition Assistance Program for Women, Infants, and Children decreased the prevalence of childhood obesity among low-income families.53
The study also demonstrated that residents living in disadvantaged areas including FD, low income, and low-access areas had a higher proportion of black residents. Black neighborhoods have been reported to have more fast-food restaurants,54 fewer supermarkets,55 fewer healthy options, lower levels of social cohesion, and worse walking environments.56 Our data shows that blacks also formed a higher proportion of those with low income, a key driver of increased CVD risk.

Limitations and Strengths

Our study has several strengths. It investigates the relationship between components of FD and cardiovascular risk factors in a region of United States where there is tremendous racial and regional disparity in the incidence of CVD. It investigates the health impact of socioeconomic and neighborhood features on subclinical CVD, including inflammation, OS, and arterial stiffness. Limitations include its cross-sectional nature where causality between income and living in FD and subclinical vascular disease cannot be established. Second, our study was conducted in a single urban area in southeastern United States and may not be generalizable to other regions. Third, geographic locations and characteristics can change with time. However, a recent update by the USDA showed relatively small change in low-income and low-access neighborhoods between 2010 and 2015 data.57 Previous studies also showed that individuals usually move into neighborhoods with similar SES across their life course.58,59

Conclusions and Implications

People living in FD had a higher prevalence of cardiovascular risk factors, inflammation, OS, and arterial stiffness. These associations are largely driven by area and individual income rather than access to healthy food. The implications of our findings are that at least in urban areas, risk of CVD seems to be associated less with access to healthy food and more with socioeconomic factors. This understanding may help to better tailor resources to affected communities and improve utilization of public health resources.

Acknowledgments

We thank the META-Health and CHDWB study population and Emory, Georgia Tech, and Morehouse General Clinical Research Center staff for their assistance and participation.

Supplemental Material

File (circcvqo_circcqo-2016-003532_supp1.pdf)
File (kelli.pdf)

References

1.
Diez Roux AV. Residential environments and cardiovascular risk. J Urban Health. 2003;80:569–589. doi: 10.1093/jurban/jtg065.
2.
Diez Roux AV, Merkin SS, Arnett D, Chambless L, Massing M, Nieto FJ, Sorlie P, Szklo M, Tyroler HA, Watson RL. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001;345:99–106. doi: 10.1056/NEJM200107123450205.
3.
Robert SA. Community-level socioeconomic status effects on adult health. J Health Soc Behav. 1998;39:18–37.
4.
O’Toole TE, Conklin DJ, Bhatnagar A. Environmental risk factors for heart disease. Rev Environ Health. 2008;23:167–202.
5.
Kim D, Diez Roux AV, Kiefe CI, Kawachi I, Liu K. Do neighborhood socioeconomic deprivation and low social cohesion predict coronary calcification?: the CARDIA study. Am J Epidemiol. 2010;172:288–298. doi: 10.1093/aje/kwq098.
6.
Morland K, Wing S, Diez Roux A, Poole C. Neighborhood characteristics associated with the location of food stores and food service places. Am J Prev Med. 2002;22:23–29.
7.
Rummo PE, Meyer KA, Boone-Heinonen J, Jacobs DR, Kiefe CI, Lewis CE, Steffen LM, Gordon-Larsen P. Neighborhood availability of convenience stores and diet quality: findings from 20 years of follow-up in the coronary artery risk development in young adults study. Am J Public Health. 2015;105:e65–e73. doi: 10.2105/AJPH.2014.302435.
8.
Economic Research Service (ERS), U.S. Department of Agriculture (USDA). Food Access Research Atlas, https://www.ers.usda.gov/data-products/food-access-research-atlas/. Accessed August 30, 2017.
9.
Ver Ploeg M, Breneman V, Farrigan T, Hamrick K, Hopkins D, Kaufman P, Lin B-H, Nord M, Smith TA, Williams R, Kinnison K, Olander C, Singh A, Tuckermanty E. Economic Research Service (ERS), U.S. Department of Agriculture (USDA). Access to Affordable and Nutritious Food-Measuring and Understanding Food Deserts and Their Consequences. Administrative Publication No. (AP-036). https://www.ers.usda.gov/webdocs/publications/42711/12716_ap036_1_.pdf?v=41055. Published June 2009. Accessed August 30, 2017.
10.
Saxe JS. Promoting healthy lifestyles and decreasing childhood obesity: increasing physician effectiveness through advocacy. Ann Fam Med. 2011;9:546–548. doi: 10.1370/afm.1263.
11.
Block JP, Subramanian SV. Moving beyond “food deserts”: reorienting United States Policies to reduce disparities in diet quality. PLoS Med. 2015;12:e1001914. doi: 10.1371/journal.pmed.1001914.
12.
Pollitt RA, Rose KM, Kaufman JS. Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review. BMC Public Health. 2005;5:7. doi: 10.1186/1471-2458-5-7.
13.
Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121:505–511. doi: 10.1161/CIRCULATIONAHA.109.886655.
14.
Thurston RC, Matthews KA. Racial and socioeconomic disparities in arterial stiffness and intima media thickness among adolescents. Soc Sci Med. 2009;68:807–813. doi: 10.1016/j.socscimed.2008.12.029.
15.
Biasucci LM; CDC; AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation. 2004;110:e560–e567. doi: 10.1161/01.CIR.0000148983.88334.80.
16.
Deverts DJ, Cohen S, Kalra P, Matthews KA. The prospective association of socioeconomic status with C-reactive protein levels in the CARDIA study. Brain Behav Immun. 2012;26:1128–1135. doi: 10.1016/j.bbi.2012.07.017.
17.
Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun. 2006;20:498–504. doi: 10.1016/j.bbi.2005.10.003.
18.
Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, Vaccarino V, Harrison DG, Quyyumi AA. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol. 2006;47:1005–1011. doi: 10.1016/j.jacc.2005.09.063.
19.
Patel RS, Ghasemzadeh N, Eapen DJ, Sher S, Arshad S, Ko YA, Veledar E, Samady H, Zafari AM, Sperling L, Vaccarino V, Jones DP, Quyyumi AA. Novel biomarker of oxidative stress is associated with risk of death in patients with coronary artery disease. Circulation. 2016;133:361–369. doi: 10.1161/CIRCULATIONAHA.115.019790.
20.
Petersen KL, Marsland AL, Flory J, Votruba-Drzal E, Muldoon MF, Manuck SB. Community socioeconomic status is associated with circulating interleukin-6 and C-reactive protein. Psychosom Med. 2008;70:646–652. doi: 10.1097/PSY.0b013e31817b8ee4.
21.
Pickle LW, Gillum RF. Geographic variation in cardiovascular disease mortality in US blacks and whites. J Natl Med Assoc. 1999;91:545–556.
22.
Gillum RF, Mehari A, Curry B, Obisesan TO. Racial and geographic variation in coronary heart disease mortality trends. BMC Public Health. 2012;12:410. doi: 10.1186/1471-2458-12-410.
23.
Casper M, Kramer MR, Quick H, Schieb LJ, Vaughan AS, Greer S. Changes in the geographic patterns of heart disease mortality in the United States: 1973 to 2010. Circulation. 2016;133:1171–1180. doi: 10.1161/CIRCULATIONAHA.115.018663.
24.
Morris AA, Zhao L, Ahmed Y, Stoyanova N, De Staercke C, Hooper WC, Gibbons G, Din-Dzietham R, Quyyumi A, Vaccarino V. Association between depression and inflammation–differences by race and sex: the META-Health study. Psychosom Med. 2011;73:462–468. doi: 10.1097/PSY.0b013e318222379c.
25.
Rask KJ, Brigham KL, Johns MM. Integrating comparative effectiveness research programs into predictive health: a unique role for academic health centers. Acad Med. 2011;86:718–723. doi: 10.1097/ACM.0b013e318217ea6c.
26.
Lenfant C, Chobanian AV, Jones DW, Roccella EJ; Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension. 2003;41:1178–1179. doi: 10.1161/01.HYP.0000075790.33892.AE.
27.
Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583–1592. doi: 10.1056/NEJMoa011090.
28.
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–3167.
29.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S1–45. doi: 10.1161/01.cir.0000437738.63853.7a.
30.
Jones DP, Liang Y. Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med. 2009;47:1329–1338. doi: 10.1016/j.freeradbiomed.2009.08.021.
31.
Patel RS, Al Mheid I, Morris AA, Ahmed Y, Kavtaradze N, Ali S, Dabhadkar K, Brigham K, Hooper WC, Alexander RW, Jones DP, Quyyumi AA. Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis. 2011;218:90–95. doi: 10.1016/j.atherosclerosis.2011.04.033.
32.
Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, Kavtaradze N, Uphoff I, Hooper C, Tangpricha V, Alexander RW, Brigham K, Quyyumi AA. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011;58:186–192. doi: 10.1016/j.jacc.2011.02.051.
33.
Morris AA, Patel RS, Binongo JN, Poole J, Al Mheid I, Ahmed Y, Stoyanova N, Vaccarino V, Din-Dzietham R, Gibbons GH, Quyyumi A. Racial differences in arterial stiffness and microcirculatory function between Black and White Americans. J Am Heart Assoc. 2013;2:e002154. doi: 10.1161/JAHA.112.002154.
34.
McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin, Newby DE, Cockcroft JR, Wilkinson IB. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension. 2006;48:602–608. doi: 10.1161/01.HYP.0000239206.64270.5f.
35.
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–1327. doi: 10.1016/j.jacc.2009.10.061.
36.
Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203–1206. doi: 10.1161/01.STR.0000065428.03209.64.
37.
Chum A, O’Campo P. Cross-sectional associations between residential environmental exposures and cardiovascular diseases. BMC Public Health. 2015;15:438. doi: 10.1186/s12889-015-1788-0.
38.
Cobb LK, Appel LJ, Franco M, Jones-Smith JC, Nur A, Anderson CA. The relationship of the local food environment with obesity: a systematic review of methods, study quality, and results. Obesity (Silver Spring). 2015;23:1331–1344. doi: 10.1002/oby.21118.
39.
Gucciardi E, Vogt JA, DeMelo M, Stewart DE. Exploration of the relationship between household food insecurity and diabetes in Canada. Diabetes Care. 2009;32:2218–2224. doi: 10.2337/dc09-0823.
40.
Suarez JJ, Isakova T, Anderson CA, Boulware LE, Wolf M, Scialla JJ. Food access, chronic kidney disease, and hypertension in the U.S. Am J Prev Med. 2015;49:912–920. doi: 10.1016/j.amepre.2015.07.017.
41.
Block JP, Christakis NA, O’Malley AJ, Subramanian SV. Proximity to food establishments and body mass index in the Framingham Heart Study offspring cohort over 30 years. Am J Epidemiol. 2011;174:1108–1114. doi: 10.1093/aje/kwr244.
42.
Larson NI, Story MT, Nelson MC. Neighborhood environments: disparities in access to healthy foods in the U.S. Am J Prev Med. 2009;36:74–81. doi: 10.1016/j.amepre.2008.09.025.
43.
Morland K, Diez Roux AV, Wing S. Supermarkets, other food stores, and obesity: the atherosclerosis risk in communities study. Am J Prev Med. 2006;30:333–339. doi: 10.1016/j.amepre.2005.11.003.
44.
Laxy M, Malecki KC, Givens ML, Walsh MC, Nieto FJ. The association between neighborhood economic hardship, the retail food environment, fast food intake, and obesity: findings from the Survey of the Health of Wisconsin. BMC Public Health. 2015;15:237. doi: 10.1186/s12889-015-1576-x.
45.
Holsten JE. Obesity and the community food environment: a systematic review. Public Health Nutr. 2009;12:397–405. doi: 10.1017/S1368980008002267.
46.
Gebreab SY, Diez Roux AV, Brenner AB, Hickson DA, Sims M, Subramanyam M, Griswold ME, Wyatt SB, James SA. The impact of lifecourse socioeconomic position on cardiovascular disease events in African Americans: the Jackson Heart Study. J Am Heart Assoc. 2015;4:e001553. doi: 10.1161/JAHA.114.001553.
47.
Janković J, Erić M, Stojisavljević D, Marinković J, Janković S. Socio-Economic differences in cardiovascular health: findings from a cross-sectional study in a middle-income country. PLoS One. 2015;10:e0141731. doi: 10.1371/journal.pone.0141731.
48.
Mackenbach JP, Cavelaars AE, Kunst AE, Groenhof F. Socioeconomic inequalities in cardiovascular disease mortality; an international study. Eur Heart J. 2000;21:1141–1151. doi: 10.1053/euhj.1999.1990.
49.
Wing S, Casper M, Davis W, Hayes C, Riggan W, Tyroler HA. Trends in the geographic inequality of cardiovascular disease mortality in the United States, 1962-1982. Soc Sci Med. 1990;30:261–266.
50.
Bower KM, Thorpe RJ, Rohde C, Gaskin DJ. The intersection of neighborhood racial segregation, poverty, and urbanicity and its impact on food store availability in the United States. Prev Med. 2014;58:33–39. doi: 10.1016/j.ypmed.2013.10.010.
51.
Chung C, Myers SL Do the poor pay more for food? An analysis of grocery store availability and food price disparities. J Consum Aff. 1999:276–296.
52.
Brace A, Matthews T, Finkelstein B, Beall D. The relationship between food deserts, farmers’ markets and food assistance in Georgia census tracts. J Ga Public Health Assoc. 2016;5:8.
53.
Pan L. Trends in obesity among participants aged 2–4 years in the special supplemental nutrition program for women, infants, and children—United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;65:1256–1260.
54.
Block JP, Scribner RA, DeSalvo KB. Fast food, race/ethnicity, and income: a geographic analysis. Am J Prev Med. 2004;27:211–217. doi: 10.1016/j.amepre.2004.06.007.
55.
Block D, Kouba J. A comparison of the availability and affordability of a market basket in two communities in the Chicago area. Public Health Nutr. 2006;9:837–845.
56.
Kaiser P, Auchincloss AH, Moore K, Sánchez BN, Berrocal V, Allen N, Roux AV. Associations of neighborhood socioeconomic and racial/ethnic characteristics with changes in survey-based neighborhood quality, 2000-2011. Health Place. 2016;42:30–36. doi: 10.1016/j.healthplace.2016.08.001.
57.
Rhone A, Ploeg MV, Dicken C, Williams R, Breneman V. Low-Income and Low-Supermarket-Access Census Tracts, 2010–2015. Economic Information Bulletin. 2017:21.
58.
Sampson RJ, Sharkey P. Neighborhood selection and the social reproduction of concentrated racial inequality. Demography. 2008;45:1–29.
59.
Glass TA, Bilal U. Are neighborhoods causal? Complications arising from the ‘stickiness’ of ZNA. Soc Sci Med. 2016;166:244–253. doi: 10.1016/j.socscimed.2016.01.001.

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Circulation: Cardiovascular Quality and Outcomes
Circulation: Cardiovascular Quality and Outcomes
PubMed: 28904075

History

Received: 27 December 2016
Accepted: 6 July 2017
Published in print: September 2017
Published online: 13 September 2017

Permissions

Request permissions for this article.

Keywords

  1. coronary disease
  2. epidemiology
  3. hypertension
  4. prevalence
  5. risk factors

Subjects

Authors

Affiliations

Heval M. Kelli, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Muhammad Hammadah, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Hina Ahmed, MPH
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Yi-An Ko, PhD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Matthew Topel, MD, MSc
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Ayman Samman-Tahhan, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Mossab Awad, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Keyur Patel, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Kareem Mohammed, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Laurence S. Sperling, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Priscilla Pemu, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Viola Vaccarino, MD, PhD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Tene Lewis, PhD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Herman Taylor, MD, MPH
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Greg Martin, MD, MSc
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Gary H. Gibbons, MD
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).
Arshed A. Quyyumi, MD, FRCP
From the Emory Clinical Cardiovascular Research Institute (H.M.K., M.H., H.A., M.T., A.S.-T., M.A., K.P., K.M., L.S.S., V.V., A.A.Q.), Rollins School of Public Health, Emory University School of Medicine (Y.-A.K., V.V., T.L.), and Predictive Health Institute (G.M.), Emory University, Atlanta, GA; Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (P.P., H.T.); and National Heart, Lung, and Blood Institute, Bethesda, MD (G.H.G.).

Notes

Correspondence to Arshed A. Quyyumi, MD, Division of Cardiology, Department of Medicine, Emory University School of Medicine, 1462 Clifton Rd, NE Suite 507, Atlanta, GA 30322. E-mail [email protected]

Disclosures

None.

Sources of Funding

The META-Health study was supported by funding from National Institutes of Health/National Heart, Blood, and Lung Institute 1 U01 HL079156-01 (Dr Quyyumi) and 1 U01 HL79214-01 (Dr Gibbons); National Institutes of Health, National Center for Research Resources grant M01-RR00039 for the Emory General Clinical Research Center; National Institutes of Health/National Center for Research Resources 5P20RR11104 for the Morehouse Clinical Research Center. The CHDWB study was supported by the Marcus and Woodruff Foundations, Atlanta, GA; and the Emory University/Georgia Tech Predictive Health Institute and award UL1 RR025008 and UL1 TR000454 from the Clinical and Translational Science Award Program, National Institutes of Health, National Center for Research Resources and National Center for Advancing Translational Sciences. Additional support comes from National Institutes of Health grants 5P20HL113451, 5P01HL101398, 1R56HL126558, 1U10HL110302, U01HL079156, R01HL109413, R01HL125246, and K24HL077506. Dr Kelli has been supported by the Abraham J. and Phyllis Katz Foundation and National Heart, Blood, and Lung Institute T32 THL130025A.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Adverse socioeconomic factors are associated with a widening gap in one-year health-related quality of life after acute myocardial infarction, Scientific Reports, 15, 1, (2025).https://doi.org/10.1038/s41598-025-04604-1
    Crossref
  2. Local Infrastructure and Economy Predicts Traffic Related Fatalities in Children, Journal of Pediatric Surgery, 60, 6, (162109), (2025).https://doi.org/10.1016/j.jpedsurg.2024.162109
    Crossref
  3. Psychosocial stress and cardiovascular disease, American Journal of Preventive Cardiology, 22, (100968), (2025).https://doi.org/10.1016/j.ajpc.2025.100968
    Crossref
  4. The Association between Community Food Environments and Health Outcomes in High-Income Countries: A Systematic Literature Review, Current Nutrition Reports, 14, 1, (2025).https://doi.org/10.1007/s13668-025-00662-z
    Crossref
  5. Global Burden of Cardiovascular Disease Attributable to Sugar‐Sweetened Beverages in Middle‐Aged Adults: An Age‐Period‐Cohort Modelling Study, Journal of the American Heart Association, 14, 9, (2025)./doi/10.1161/JAHA.124.035978
    Abstract
  6. Association Between Sociodemographic Factors and Self-Reported Diabetic Retinopathy: A Cross-sectional, Population-Based Analysis, American Journal of Ophthalmology, 271, (138-148), (2025).https://doi.org/10.1016/j.ajo.2024.11.008
    Crossref
  7. Closing the Gap: Digital Innovations to Address Hypertension Disparities, Current Cardiology Reports, 27, 1, (2025).https://doi.org/10.1007/s11886-024-02171-x
    Crossref
  8. Structural inequities and chronic disease health outcomes: Cardiovascular disease, hypertension, and stroke, Structural Inequalities and Health Outcomes for Chronic Disease, (65-102), (2025).https://doi.org/10.1016/B978-0-443-23750-8.00014-X
    Crossref
  9. The Association of Food Security With Hypertensive Disorders of Pregnancy: A National Health Interview Survey Analysis, The Journal of Clinical Hypertension, 27, 1, (2024).https://doi.org/10.1111/jch.14952
    Crossref
  10. Social, Racial, and Cultural Considerations in Hypertension in Older Adults, Clinics in Geriatric Medicine, 40, 4, (529-538), (2024).https://doi.org/10.1016/j.cger.2024.04.010
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

Association Between Living in Food Deserts and Cardiovascular Risk
Circulation: Cardiovascular Quality and Outcomes
  • Vol. 10
  • No. 9

Purchase access to this journal for 24 hours

Circulation: Cardiovascular Quality and Outcomes
  • Vol. 10
  • No. 9
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Figures

Tables

Media

Share

Share

Share article link

Share

Comment Response